Valiant Capital Management’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$191M Buy
7,474,231
+622,906
+9% +$14.7M 7.72% 5
2026
Q1
$102M Buy
6,851,325
+514,901
+8% +$8.78M 5.89% 5
2025
Q4
$92.3M Sell
6,336,424
-146,679
-2% -$2.56M 5.22% 5
2025
Q3
$116M Buy
6,483,103
+1,681,579
+35% +$24.7M 8% 2
2025
Q2
$82M Buy
4,801,524
+379,000
+9% +$3.79M 4.49% 8
2025
Q1
$32M Buy
4,422,524
+97,500
+2% +$1.11M 2.34% 17
2024
Q4
$60.8M Buy
4,325,024
+622,081
+17% +$9.19M 3.85% 5
2024
Q3
$43.9M Sell
3,702,943
-851,186
-19% -$8.82M 2.43% 9
2024
Q2
$42.4M Buy
+4,554,129
New +$23.3M 2.26% 13

Other funds holding CORZ

Valiant Capital Management's CORZ Position: Q2 2026 in Review

Valiant Capital Management increased its Core Scientific (CORZ) stake by 9.1% in Q2 2026, buying an estimated $14.7M and bringing the position to 7,474,231 shares worth $191M. The position accounts for 7.72% of the portfolio, ranked #5.

Valiant Capital Management first reported a position in CORZ in Q2 2024 and has held it in 9 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Valiant Capital Management held 7,474,231 shares of Core Scientific worth $191M as of Q2 2026.
  • Valiant Capital Management bought 622,906 Core Scientific shares in Q2 2026, an estimated $14.7M.
  • Core Scientific made up 7.72% of Valiant Capital Management's portfolio in Q2 2026, its #5 holding.
  • Valiant Capital Management first reported a position in Core Scientific in Q2 2024 and has held it in 9 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Valiant Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.